FDA Approved: IVRA — Original Application (Apotex Corp)

View source ↗

Summary

FDA approved Apotex Corp's original application for IVRA, an intravenous melphalan hydrochloride formulation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Ovarian Cancer

Drugs mentioned

• IVRA (melphalan hydrochloride)

Snippet

ORIG AP for IVRA (MELPHALAN HCL)